Table 1.
Laboratory and clinical data
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Presentation after dose | 2 | 1 | 2 |
| Previous COVID-19 infection | No | Yes | No |
| Troponin (initial/peak) | 8.1/12.5 (normal <0.05 ng/mL) | 13.3/13.3 (normal <0.05 ng/mL) | 4.9/27.7 (normal <0.05 ng/mL) |
| CRP (initial/peak) | 75/87 (normal 0.1-1.7 mg/L) | Initial: 60 (High-sensitivity, normal <8.1 mg/L) Peak: 55 (0.1-1.7 mg/L) | 37/37 (normal <5.0 mg/L) |
| WBC on presentation | 12 (normal 4.5-13.2 x10E9/L) | 7.4 | 13.6 |
| ALC* on presentation (%) | 15 (normal 20-70) | 27 | 16 |
| COVID-19 PCR | Negative | Negative | Negative |
| COVID-19 Antibody (IgG against nucleocapsid protein) | Negative | Positive 8.2 (normal <0.8, intermediate 0.8-1, positive >1) | Negative |
| Treatments | |||
| IVIG | 2 g/kg | 2 g/kg | 2 g/kg |
| Aspirin | Yes | Yes | Yes |
| Steroids | Steroid taper | Steroid taper | Steroid taper |
| Outcome | Recovery | Recovery | Recovery |
ALC=Absolute lymphocytic count